Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing

Application of a Sanger-Based External Quality Assurance Strategy for the Transition of HIV-1 Drug Resistance Assays to Next Generation Sequencing

The National Institute of Allergy and Infectious Diseases (NIAID) Virology Quality Assurance (VQA) established a robust proficiency testing program for Sanger sequencing (SS)-based HIV-1 drug resistance (HIVDR) testing in 2001. While many of the lessons learned during the development of such program...

Full description

Bibliographic Details
Main Authors: Cheryl Jennings, Neil T. Parkin, Daniel J. Zaccaro, Rupert Capina, Paul Sandstrom, Hezhao Ji, Donald J. Brambilla, James W. Bremer
Format: Article
Language:English
Published: MDPI AG 2020-12-01
Series:Viruses
Subjects:
HIV-1 drug resistance
next-generation sequencing
external quality assurance
Sanger sequencing
Online Access:https://www.mdpi.com/1999-4915/12/12/1456

Internet

https://www.mdpi.com/1999-4915/12/12/1456

Similar Items